CD274 and neoplasm: These molecules were radiolabelled with different PET isotopes and obtained a clear visualization of PD-L1 positive tumours in comparison to PD-L1 negatives, suggesting them as new radiopharmaceuticals with translational applications for human immune-checkpoints imaging [129,130,131].